ESC Premium Access

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

Congress Session

About the speaker

Doctor Giuseppe Vergaro

Gabriele Monasterio Foundation, Pisa (Italy)
5 presentations
0 follower

4 more presentations in this session

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

Speaker: Doctor S. Kiddle (Cambridge, GB)

Thumbnail

Cysteine-rich angiogenic inducer 61 (CCN1) independently predicts all-cause mortality in patients with dilated cardiomyopathy

Speaker: Doctor R. Klingenberg (Bad Nauheim, DE)

Thumbnail

Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure

Speaker: Doctor G. Vergaro (Pisa, IT)

Thumbnail

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

Speaker: Doctor A. Reese-Petersen (Copenhagen, DK)

Thumbnail

Access the full session

Biomarkers to improve prognostication in heart failure: what's new?

Speakers: Doctor G. Vergaro, Doctor S. Kiddle, Doctor R. Klingenberg, Doctor G. Vergaro, Doctor A. Reese-Petersen
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

Pathophysiology and evolving definition of cardiogenic shock.

19 March 2022

ACVC Premium Access

Acute PE: risk stratification and interest for decision of reperfusion.

19 March 2022

ESC Premium Access

Heart failure as a complication of covid-19 infection: systematic review and meta-analysis

27 August 2021

This platform is supported by

logo Novo Nordisk